Kidney cancer research is a fast-moving space. The following Advisory Board members provide guidance and ensure we stay up-to-date.
“Kidney cancer is the ideal sandbox for new approaches, and without a doubt these approaches can, should, and will be suitable for other cancers.”
Dr. Hans Hammers
Mehmet Bilen, MD
Director, Genitourinary Medical Oncology Program, Winship Cancer Institute of Emory University.
Associate Medical Director, Phase I Unit,
Winship Cancer Institute of Emory University
Gennady Bratslavsky, MD
James Brugarolas, MD, PhD
Toni Choueiri, MD
Rachel Giles, MD
University Medical Center Utrecht, The Netherlands
Chair – IKCC Board
Hans Hammers, MD, PHD
Eric Jonasch, MD
Payal Kapur, MD
Marc Michaelson, MD, PhD
Mehdi Mollapour, PhD
Eric Singer, MD, MA, FACS
Ramaprasad Srinivasan, MD, PHD
KCRS is a meeting focused on basic, translational, and clinical kidney cancer research. This meeting is fueled by the ideas and research funded through the Department of Defense CDMRP-KCRP awards.
The goal for KCRS is to present the important, innovative research funded by the KCRP. We also aim to connect researchers from around the world to share their work.
Join us on October 7 and 8 for this dynamic, interactive meeting focused on the latest basic science, translational, and clinical research in kidney cancer.
KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Programs (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community.